[1] CZAJA AJ，MANNS MP. Advances in the diagnosis，pathogenesis，and management of autoimmune hepatitis[J]. Gastroenterology，2010，139:58-72.
[2] LONGHI MS，MA Y，MIELI-VERGANI G，et al. Aetiopathogenesis of autoimmune hepatitis[J]. J Autoimmun，2010，34:7-14.
[3] RONG G，ZHOU Y，XIONG Y，et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis:the serum cytokine profile and peripheral cell population[J]. Clin Exp Immunol，2009，156:217-225.
[4] HIRSCHFIELD GM，HEATHCOTE J.T regulatory cells and autoimmune liver disease[J]. Liver Int，2008，28:155-157.
[5] WIEGARD C，FRENZEL C，HERKEL J，et a1． Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells[J]． Hepatology，2005，2（1）:193-199.
[6] LONGHI MS，HUSSAIN MJ，MITRY RR，et a1． Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis[J]. J Immunol，2006，176（7）:4484-4491.
[7] LAN RY，CHENG C，LIAN ZX，et a1. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis[J]. Hepatology，2006，43（4）:729-737.
[8] SASAKI M，IKEDA H，SAWADA S，et a1. Naturally-occnrring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis[J]. J Clin Pathol，2007，60（10）：1102-1107．
[9] TESMER LA，LUNDY SK，SARKAR S，et al. Th17 cells in human disease[J]. Immunol Rev，2008，223:87-113.
[10] IVANOV II，MCKENZIE BS，ZHOU L，et a1. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+T helper cells[J].Cell，2006，126（6）:1121-1133.
[11] LAN RY，SALUNGA TL，TSUNEYAMA K，et a1. Hepatic IL-17 responses in human and murine primary biliary cirrhosis[J]． J Autoimmun，2009，32（1）：43-51．
[12] KORN T，BETTELLI E，OUKKA M，et a1. IL-17 and Th17 Cells[J]. Annu Rev Immunol，2009，27:485-517
[13] UCCELLI A，MORETTA L，PISTOIA V. Mesenchymal stem cells in health and disease[J]. Nat Rev Immunol，2008，8（9）:726 736.
[14] NAUTA AJ，FIBBE WE.Immunomodulatory properties of mesenchymal stromal cells[J]. Blood，2007，110（10）:3499-3506.
[15] PUISSANT B，BARREAU C，BOURIN P，et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells:comparison with bone marrow mesenchymal stem cells[J]. Br J Haematol，2005，129:118-129.
[16] CORCIONE A，BENVENUTO F，FERRETTI E，et al. Human mesenchymal stem cells modulate B-cell functions[J]. Blood，2006，7（1）:367-372.
[17] BASSI EJ，AITA CAM，CAMARA NOS. Immune regulatory properties of multipotent mesenchymal stromal cells:Where do we stand[J]. World J Stem Cells，2011，3（1）:1-8.
[18] RAFFAGHELLO L，BIANCHI G，BERTOLOTTO M，et al. Human mesenchymal stem cells inhibit neutrophil apoptosis:a model for neutrophil preservation in the bone marrow niche[J]. Stem Cells，2008，26（1）:151-162.
[19] VITO P，LIZZIA R.Potential of mesenchymal stem cells for the therapy of autoimmune diseases[J]. Clin Immunol，2010，6（2）:211-218.
[20] DI NICOLA M，CARLO-STELLA C，MAGNI M，et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli[J]. Blood， 2002，99（10）:3838-3843.
[21] HIROSHI Y，ALEJANDRO S，BIJU P，et al. Mesenchymal stem cells：Mechanisms of immunomodulation and homing[J]. Cell Transplant，2010，19（6）:667-679.
[22] SELMANI Z，NAJI A，ZIDI I，et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25high FOXP3+ regulatory T cell[J]. Stem Cells，2008，26（1）:212-222.
[23] SPAGGIARI GM，CAPOBIANCO A，ABDELRAZIK H，et al. Mesenchymal stem cells inhibit natural killer-cell proliferation，cytotoxicity，and cytokine production:role of indoleamine 2，3-dioxygenase and prostaglandin E2[J]. Blood，2008，111（3）:1327-1333.
[24] GHANNAM S，PENE J，TORCY-MOQUET G，et al. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype[J]. J Immunol，2010，185:302-312.
[25] DANDAN W，HUAYONG Z，JUN L，et al. Effect of allogeneic bone marrow-derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model[J]. Clin Exp Med，2010，11（1）:25-32.
[26] ROSLAND GV，SVENDSEN A，TORSVIK A，et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation[J]. Cancer Res，2009，69（13）:5331-5339. |
